---
title: CDMO Daily News — October 4, 2026
slug: daily-news-2026-10-04-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: October 4 CDMO daily: Lonza and Asimov Partner on Scalable Lentiviral Vector Manufacturing for Gene Therapy — Lonza's expanded lentiviral vector GMP…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-10-04-cdmo
published_at: 2026-10-04T00:00:36.311Z
last_updated: 2026-10-04T00:01:07.566Z
---

### [Lonza](/companies/lonza) and [Asimov](/companies/asimov) Partner on Scalable Lentiviral Vector Manufacturing for Gene Therapy
- [Lonza](/companies/lonza) and [Asimov](/companies/asimov) are collaborating to advance lentiviral vector manufacturing using Asimov's LV Edge stable producer cell lines combined with Lonza's process development, scale-up, and GMP capabilities.
- The partnership addresses manufacturability challenges in current multi-plasmid transient transfection methods by developing stable, program-specific manufacturing strategies to improve scalability and batch-to-batch consistency.
- The companies will establish a feasibility-first framework spanning transgene optimization, cell line development, process development, analytics, scale-up, GMP production, and CMC readiness for in vivo and ex vivo lentiviral programs.

**Operational Impact**

[Lonza](/companies/lonza)'s expanded lentiviral vector GMP manufacturing capability—integrated with [Asimov](/companies/asimov)'s stable cell line platform—creates a differentiated offering for gene therapy developers seeking to de-risk manufacturing scale-up and reduce time-to-clinic for in vivo LVV programs.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/lonza-asimov-partner-to-advance-scalable-lentiviral-vector-manufacturing)*

## References

1. [Contract Pharma Breaking News RSS — Lonza and Asimov Partner on Scalable Lentiviral Vector Manufacturing for Gene Therap](https://www.contractpharma.com/breaking-news/lonza-asimov-partner-to-advance-scalable-lentiviral-vector-manufacturing)

Source: https://www.cdmo.directory/posts/daily-news-2026-10-04-cdmo